Advertisement

The Scientist

» FDA

Most Recent

image: Neurosurgeons Banned from Research

Neurosurgeons Banned from Research

By | July 24, 2012

After treating terminally ill patients with an unauthorized experimental probiotic procedure, two California doctors can no longer participated in human research.

0 Comments

image: FDA Spies on its Own

FDA Spies on its Own

By | July 17, 2012

The federal agency's surveillance of staffers feared to be leaking confidential information about medical devices was wider than previously thought.

0 Comments

image: Sidestepping the Synthetic Drug Ban

Sidestepping the Synthetic Drug Ban

By | July 16, 2012

Chemists are already finding ways to circumvent a new federal law cracking down on marijuana and methamphetamine mimics.

0 Comments

image: Obama Signs FDA Bill

Obama Signs FDA Bill

By | July 11, 2012

The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.

0 Comments

image: Pharma Company Sues FDA

Pharma Company Sues FDA

By | July 10, 2012

The maker of a pregnancy medication takes action against the federal agency for not stopping pharmacies from making and selling cheaper versions of the drug.

2 Comments

image: A Placebo for Schizophrenia?

A Placebo for Schizophrenia?

By | June 26, 2012

The placebo effect in clinical trials of the mental disorder has increased over the past decade.

1 Comment

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.

2 Comments

image: New FDA Review Process Debated

New FDA Review Process Debated

By | June 20, 2012

Industry experts discuss the agency’s plans to make the drug approval process more transparent.

0 Comments

image: @Pharma Branching Out

@Pharma Branching Out

By | June 11, 2012

More than half of pharmaceutical companies on Twitter use more than one handle.

0 Comments

image: FDA OKs Early Stage Trials

FDA OKs Early Stage Trials

By | June 5, 2012

The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.

1 Comment

Advertisement

Popular Now

  1. First Data from Anti-Aging Gene Therapy
  2. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  3. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  4. Locating Language within the Brain
Advertisement
Diagenode
Diagenode
Advertisement
RayBioTech